A high incidence of FLT3-ITD mutations has been reported in AML patients with NUP98::NSD1 fusion, and it has been hypothesized that the interaction between NUP98::NSD1 and FLT3-ITD confers a poor prognosis in this group [76,77]. This evidence concerns the gene FLT3 and acute myeloid leukemia.